Kafa a cikin 2015 tare da bin "bautawa al'umma, kiwon lafiya duniya"mayar da hankali a kan R & D , samarwa , ci gaba , tallace-tallace da kuma sabis na In Vitro diagnostic kayayyakin da dabbobi kayayyakin.
Ƙirƙirar da ƙware ƙwararrun fasahar sabbin fasahohi don albarkatun ƙasa da dogaro da shekaru na ci gaba da saka hannun jari na R&D da shimfidar ma'ana, testsea ya gina dandamalin gano ƙwayoyin cuta, dandamalin gano ƙwayoyin ƙwayoyin cuta, dandamalin binciken tushen furotin, da albarkatun halitta.
Dangane da dandamali na fasaha na sama, Testsea ya haɓaka samfuran samfuran zuwa saurin gano cutar ƙwayar cuta ta corona, cututtukan zuciya, kumburi, ƙari, cututtukan cututtuka, shan ƙwayoyi, ciki, da dai sauransu samfuranmu ana amfani da su sosai a cikin saurin ganewar asali da inganci. lura da cututtuka masu tsanani da masu tsanani, gano magungunan kiwon lafiya na iyaye mata da yara, gwajin barasa, da sauran fannoni da tallace-tallace sun rufe fiye da kasashe da yankuna 100 a fadin duniya.
Kamfanonin fasahar kere-kere da ke mai da hankali kan samfuran binciken likitancin in vitro.
Kamfanin yanzu yana da cikakken tsarin R & D, kayan aikin samarwa da tsarkakewa
bita don in vitro diagnostic kayan aikin I reagents I albarkatun kasa don POCT, biochemistry, rigakafi da kwayoyin ganewar asali
A shekarar 2015, Hangzhou testsea Biotechnology co., Ltd aka kafa ta wanda ya kafa kamfanin tare da kwararrun tawagar daga kasar Sin Academy of Sciences da kuma Zhejiang University.
A cikin 2019, kafa ƙungiyar tallace-tallacen kasuwancin waje don haɓaka kasuwannin ketare
Babban Aiki
Bayan shekaru da yawa na ci gaban fasaha, ƙaddamar da samfuran gasa iri-iri, kamar na'urorin gwajin gaggawa na dabbobi, gwajin gano zazzabin Swin.
Tare da barkewar annobar cutar corona a ƙarshen 2019, kamfaninmu da masanin ilimin kimiyya na Kwalejin Kimiyya ta kasar Sin sun haɓaka da sauri tare da ƙaddamar da gwajin COVID-19, tare da samun takardar shedar siyarwa kyauta tare da amincewar ƙasashe da yawa, suna hanzarta shawo kan COVID-19. .
TESTSEALABS samfuran gwajin antigen na COVID-19 sun sami takaddun shaida ta EU CE, Jerin PEI&BfArm na Jamus, TGA, UK MHRA, Thailand FDA, ect
Matsar zuwa Sabuwar masana'anta-56000㎡
Domin gamsar da kamfanin ta ƙara samar iya aiki bukatun, sabon masana'antu da 56000㎡ aka kammala, sa'an nan shekara-shekara samar iya aiki ya karu daruruwan sau.
Ƙungiya ingantaccen haɗin gwiwa, cimma ƙimar tallace-tallace na farko na biliyan 1.
Tare da ƙarfin haɗin gwiwar ƙungiya mai ƙarfi da ƙoƙarin da ba a yi ba, Testsea ya riga ya sami lasisin izini fiye da 50, 30+ rajista a cikin ƙasashen waje.
Tare da hangen nesa na "Ƙungiyar Hidima, Duniya mai Lafiya", mun himmatu don ba da gudummawa ga lafiyar ɗan adam ta hanyar samar da ingantattun samfuran bincike da haɓaka ingantaccen ganewar cututtuka ga duk ɗan adam.
"Mutunci, inganci da alhakin" shine falsafar da muke bi, kuma Testsea yayi ƙoƙari don haɓakawa a matsayin kamfani mai mahimmanci, mai kulawa wanda ke mutunta al'umma da muhalli, yana sa ma'aikatansa suyi alfahari da samun amincewa na dogon lokaci na abokin tarayya.
Mai sauri, sauri, mai hankali da kuma daidai, Testsea Biologicals yana nan don taimaka muku da gwajin gano ku.
Testsea yana ƙalubalantar ci gaban fasaha tare da sabbin ƙoƙarce-ƙoƙarce don cimma duk yuwuwar. Muna ci gaba da bincike da haɓaka samfuran da suka fi inganci, tare da tunani mai kyauta da ƙirƙira, da sauri da sassauƙar al'adun ƙungiyoyi don ɗaukar su.
Sabbin kayayyaki daga Testsea suna farawa da gwagwarmaya don inganta rayuwar mutane da ƙarin wadata. Mutane a ƙasashe da yawa sun damu game da samfuran da suka fi buƙata kuma sun himmatu wajen haɓaka samfuran da za su amfani rayuwarsu.
Testsea yana da alhakin zamantakewa don yin samfurori masu inganci waɗanda ke ba mutane da dabbobi damar rayuwa mai kyau ta hanyar ganewar asali. Za mu ci gaba da ba da kanmu ta hanyar ci gaba da ƙoƙarin ba da kwanciyar hankali ga masu zuba jari.